Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker.
Source link
Trending
- What’s likely to move the market
- Lightshed’s Walter Piecyk on why he thinks Apple needs a new CEO
- Asia stock markets today: live updates
- AI rollout rattles Teleperformance, but some say the stock could double
- Fast Money: C, BA, CAT, QBTS
- Eli Manning not interested in ownership bid
- Asset manager names 3 stocks to play the undervalued UK market
- Nvidia’s latest milestone shows this is still the AI bull market